Noninvasive Biomarkers That Predict Treatment Benefit from Biologic Therapies in Asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Noninvasive Biomarkers That Predict Treatment Benefit from Biologic Therapies in Asthma

Published:2013-12 Issue:Supplement Volume:10 Page:S206-S213
ISSN:2325-6621
Container-title:Annals of the American Thoracic Society
language:en
Short-container-title:Annals ATS

Author:

Arron Joseph R.,Choy David F.,Scheerens Heleen,Matthews John G.

Publisher

American Thoracic Society

Subject

Pulmonary and Respiratory Medicine

Reference50 articles.

1. Lessons from 60 years of pharmaceutical innovation

2. Redefining Approaches to Asthma

3. What is severe asthma?

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice;World Allergy Organization Journal;2024-03

2. Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment;International Journal of Molecular Sciences;2023-03-16

3. Eosinophilic and noneosinophilic asthma: Beyond severe asthma;Asthma in the 21st Century;2023

4. Sputum Inflammatory Cells and their Impact on Asthma Control in Adults: A Prospective Study;The Indian Journal of Chest Diseases and Allied Sciences;2022-12-05

5. Identifying clinical and demographic characteristic differences between eosinophilic and non-eosinophilic asthma and detecting predictors of eosinophilic asthma among Egyptian asthmatic patients;The Egyptian Journal of Bronchology;2022-10-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP